Lung Cancer Trial, Recruiting (NCT05736029)

Lung Cancer Trial, Recruiting NCT05736029 Sponsor: OncoHost Ltd. Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05736029 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are willing and able to give their informed consent before any study-related procedures begin.
People who are male or female and are at least 18 years old.
People whose general physical health and ability to carry out daily activities falls within a certain range, known as an ECOG performance status of 0, 1, or 2 — this broadly means people who are fully active, have some limitations but are up and about, or are capable of self-care but unable to do active work (confirm with trial site).

Who may not be able to join:

People who have had another active cancer that required systemic treatment (such as chemotherapy or similar) within the past 2 years before starting the trial.
People who have a significant cognitive or mental health condition that would prevent them from fully understanding what their participation in the study involves.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ronan J Kelly, MD MBA, Chief of Oncology Baylor Scott & White Health System

Phone: 97248537557

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05736029

Sponsor: OncoHost Ltd.

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

Trial contact: 97248537557

More information: https://clinicaltrials.gov/study/NCT05736029

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are willing and able to give their informed consent before any study-related procedures begin.
People who are male or female and are at least 18 years old.
People whose general physical health and ability to carry out daily activities falls within a certain range, known as an ECOG performance status of 0, 1, or 2 — this broadly means people who are fully active, have some limitations but are up and about, or are capable of self-care but unable to do active work (confirm with trial site).

Who may not be able to join:

People who have had another active cancer that required systemic treatment (such as chemotherapy or similar) within the past 2 years before starting the trial.
People who have a significant cognitive or mental health condition that would prevent them from fully understanding what their participation in the study involves.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

OncoHost Ltd.

Registry

ClinicalTrials.gov

Start date

7 November 2022

Est. completion

1 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Overall response (OR); Overall response (OR); Overall response (OR); Overall response (OR); Overall response (OR); Overall response (OR); Overall response (OR); Overall response (OR); Plasma proteomic profile; Plasma proteomic profile; Plasma proteomic profile; Plasma proteomic profile; Plasma proteomic profile; Plasma proteomic profile; Plasma proteomic profile; Plasma proteomic profile; Plasma proteomic profile; Plasma proteomic profile; Epigenetic patterns; Epigenetic patterns; Epigenetic patterns; Epigenetic patterns; ctDNA mutation analysis; Microbiome profiling; Microbiome profiling; Mic...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov